Xbrane Sets Cash Target Ahead Of Lucentis Ambitions In 2022

Swedish Firm Names New Strategic Targets

 
• By Dean Rudge
Female eye with long eyelashes close up. Closeup shot of female gray - blue colour eye with day makeup. Beauty female eye with curl long eyelashes
Xbrane aims to launch ranibizumab in 2022 • Source: Shutterstock

More from Biosimilars

More from Products